Vitamin D for Sickle-cell Respiratory Complications
Sponsor: Gary M Brittenham, MD
Listed as NCT01443728, this PHASE2 trial focuses on Acute Chest Syndrome and Asthma and remains completed. Sponsored by Gary M Brittenham, MD, it has been updated 12 times since 2011, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Apr 2022 — Jul 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Apr 2022 [monthly]
Completed PHASE2
-
Aug 2020 — Jan 2021 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
▶ Show 7 earlier versions
-
Mar 2020 — Aug 2020 [monthly]
Active Not Recruiting PHASE2
-
May 2019 — Mar 2020 [monthly]
Active Not Recruiting PHASE2
-
Apr 2019 — May 2019 [monthly]
Active Not Recruiting PHASE2
-
Jun 2018 — Apr 2019 [monthly]
Active Not Recruiting PHASE2
-
Jul 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE2
-
Feb 2017 — Jul 2017 [monthly]
Active Not Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE2
First recorded
Dec 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Gary M Brittenham, MD
For direct contact, visit the study record on ClinicalTrials.gov .